Sodium Polystyrene Sulfonate · SODIUM POLYSTYRENE SULFONATE 4.1 meq/g · Powder, For Suspension · Oral; Rectal · Chartwell RX, LLC
NDC 62135-0340-11 · 10 BOTTLE in 1 BOX / 15 g in 1 BOTTLE · ANDA · View full market →
7 companies supply this market — a reasonable cushion if one runs into trouble. One of its named manufacturing plants, Chartwell Pharmaceuticals Congers, LLC., failed FDA inspectionwithin the last two years — the agency’s most serious outcome.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | SODIUM POLYSTYRENE SULFONATE 4.1 meq/g | Jul 15, 2026 | Sep 3, 2026 |
| Atlantic Biologicals Corp. | SODIUM POLYSTYRENE SULFONATE 4.1 meq/g | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | SODIUM POLYSTYRENE SULFONATE 4.1 meq/g | Jul 15, 2026 | Sep 2, 2026 |
| CMP Pharma, Inc. | SODIUM POLYSTYRENE SULFONATE 1 g/g | Jul 15, 2026 | Sep 2, 2026 |
| Epic Pharma, LLC | SODIUM POLYSTYRENE SULFONATE 4.1 meq/g | Jul 15, 2026 | Sep 2, 2026 |
| PuraCap Laboratories, LLC | SODIUM POLYSTYRENE SULFONATE 4.1 meq/g | Jul 15, 2026 | Sep 2, 2026 |
| Sunrise Pharmaceutical, Inc. | SODIUM POLYSTYRENE SULFONATE 4.1 meq/g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Sodium Polystyrene Sulfonate — NDC 62135-0340-11," retrieved September 3, 2026, https://drugdashboards.com/drug/62135034011.
Free to cite with attribution — see how the data is put together.